Forecasting Stories

Silvercrest Asset Long Term Debt to Equity is most likely to slightly decrease in the upcoming years. The last year's value of Long Term Debt to Equity was reported at 0.13. The current Calculated Tax Rate is estimated to increase to 21.07, while Revenue Per Employee is projected to decrease to roughly 721.5 K. The underlying intention for this short outlook is to concentrate on Silvercrest as an investment oportunity for April. We will examine why recent Silvercrest Asset price moves suggest a bounce in April.
  over a year ago at Macroaxis 
By Raphi Shpitalnik
Raphi Shpitalnik
InTest Market Capitalization is comparatively stable at the moment as compared to the past year. InTest reported Market Capitalization of 159.06 Million in 2022. Interest Coverage is likely to gain to 1.31 in 2023, whereas Tangible Asset Value is likely to drop slightly above 58.5 M in 2023. The underlying rationale behind this short perspective is to review InTest as an investment oportunity for April. We will break down why recent InTest price moves suggest a bounce in April.
  over a year ago at Macroaxis 
By Ellen Johnson
Ellen Johnson
WhiteHorse Finance Asset Turnover is most likely to slightly decrease in the upcoming years. The last year's value of Asset Turnover was reported at 0.09. The current EBITDA Margin is estimated to increase to 0.43, while Average Equity is projected to decrease to roughly 356 M. The intention for this outlook is to forecast a future value of WhiteHorse Finance using technical analysis. What exactly are WhiteHorse Finance stockholders should expect in April?
  over a year ago at Macroaxis 
By Gabriel Shpitalnik
Gabriel Shpitalnik
Patterson Companies Operating Margin is very stable at the moment as compared to the past year. Patterson Companies reported last year Operating Margin of 2.78. As of 2nd of March 2023, Return on Investment is likely to grow to 12.11, while Net Income Per Employee is likely to drop about 26.4 K. The fundamental rationale for this short perspective is to break down our forecasting of Patterson for insiders. We will try to forecast Patterson Companies outlook for April.
  over a year ago at Macroaxis 
By Ellen Johnson
Ellen Johnson
TuanChe ADR Enterprise Value is projected to decrease significantly based on the last few years of reporting. The past year's Enterprise Value was at 29.96 Million. The current year Market Capitalization is expected to grow to about 50 M, whereas Earnings Before Interest Taxes and Depreciation Amortization EBITDA are forecasted to decline to (91.8 M). The objective of this story is to forecast a future value of TuanChe ADR using technical analysis. What exactly are TuanChe ADR shareholders should expect in April?
  over a year ago at Macroaxis 
By Gabriel Shpitalnik
Gabriel Shpitalnik
This article will break down few interesting ideas for the current Dycom Industries investors and investors who consider a position in the company. We will inspect if investors should continue to be optimistic for the company outlook.
  over a year ago at Macroaxis 
By Aina Ster
Aina Ster
Tusimple Holdings Net Cash Flow from Financing is relatively stable at the moment as compared to the past year. Tusimple Holdings reported last year Net Cash Flow from Financing of 1.49 Billion. As of 02/27/2023, Effect of Exchange Rate Changes on Cash is likely to grow to about 238.7 K, while Free Cash Flow is likely to drop (251.5 M). The fundamental reasoning behind this short post is to break down our forecasting of Tusimple for retail investors. We will try to forecast Tusimple Holdings outlook for March.
  over a year ago at Macroaxis 
By Ellen Johnson
Ellen Johnson
Atossa Genetics Asset Turnover is comparatively stable at the moment as compared to the past year. Atossa Genetics reported Asset Turnover of 0.0018 in 2022. Book Value per Share is likely to gain to 1.09 in 2023, whereas Earnings before Tax are likely to drop (20 M) in 2023. The essential rationale behind this perspective is to break down our current position on Atossa for private investors considering to short it. We will break down why Atossa Genetics private investors may still consider a stake in the business.
  over a year ago at Macroaxis 
By Raphi Shpitalnik
Raphi Shpitalnik
Northwest Natural Accrued Expenses Turnover is very stable at the moment as compared to the past year. Northwest Natural reported last year Accrued Expenses Turnover of 44.70. As of 24th of February 2023, Cash and Equivalents Turnover is likely to grow to 41.68, while Net Income Per Employee is likely to drop about 66.6 K. The essential rationale for this perspective is to break down our current position on Northwest for insiders considering to short it. We will focus on why Northwest Natural insiders may still consider a stake in the business.
  over a year ago at Macroaxis 
By Rifka Kats
Rifka Kats
NeuroMetrix Asset Turnover is very stable at the moment as compared to the past year. NeuroMetrix reported last year Asset Turnover of 0.55. As of 22nd of February 2023, Book Value per Share is likely to grow to 3.23, while Average Assets are likely to drop about 13.3 M. The rationale for this perspective is to give insiders our take on NeuroMetrix future value. We will focus on the reasons why it could be a game-changer for NeuroMetrix insiders.
  over a year ago at Macroaxis 
By Gabriel Shpitalnik
Gabriel Shpitalnik